Research Analysts Set Expectations for PRAX Q2 Earnings
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Equities researchers at Wedbush increased their Q2 2025 earnings per share estimates for shares of Praxis Precision Medicines in a research note issued to investors on Monday, May 5th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($2.94) for […]
Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) – Equities researchers at Wedbush increased their Q2 2025 earnings per share estimates for shares of Praxis Precision Medicines in a research note issued to investors on Monday, May 5th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($2.94) for […]
